Sponsor

Titan Pharmaceuticals

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Titan Pharmaceuticals appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleNCT03250117 · lead sponsor · 2017-10-10
TERMINATED
Study of DITPA in Patients With Congestive Heart FailureNCT00103519 · lead sponsor · 2004-12-01
TERMINATED
Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung CancerNCT00073385 · lead sponsor · 2003-09-01
COMPLETED
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory MalignanciesNCT00050687 · lead sponsor · 2001-06-01
TERMINATED
STEPS Trial - Spheramine Safety and Efficacy StudyNCT00206687 · collaborator · 2003-01-08
TERMINATED
Pilot Study of Safety and Efficacy of SpheramineNCT00761436 · collaborator · 2000-02-29
TERMINATED

Sponsor roles

lead sponsor4
collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.